Association between frequency of amino acid changes in core region of hepatitis B virus (HBV) and the presence of precore mutation in Japanese HBV carriers

被引:0
|
作者
Tatsunobu Karasawa
Takuji Shirasawa
Yasuhiko Okawa
Akira Kuramoto
Noritomo Shimada
Yoshio Aizawa
Mikio Zeniya
Gotaro Toda
机构
[1] The Jikei University School of Medicine,First Department of Internal Medicine
[2] Tokyo Metropolitan Institute of Gerontology,Department of Molecular Pathology
来源
Journal of Gastroenterology | 1997年 / 32卷
关键词
hepatitis B virus; frequency of core mutations; precore stop codon; HBeAg;
D O I
暂无
中图分类号
学科分类号
摘要
To elucidate the relationship between the frequency of core mutations and precore mutation of hepatitis B virus (HBV) in Japanese HBV carriers, we investigated the nucleotide sequence of the precore/core region of HBV in 26 Japanese HBV carriers [15 who were HBe antigen-negative (HBeAg−) and 11 who were HBeAg-positive (HBeAg+)]. The number of amino acid changes (5.9±3.8) in the core region of HBV in HBeAg-carriers was significantly greater than that in the HBeAg+ carriers (1.5±1.0;P<0.005). The precore stop codon mutation was found in 93.3% of HBeAg-negative HBV carriers, while no precore mutation was found in the HBeAg-positive HBV carriers, suggesting that the frequency of core mutations may be associated with the presence of the precore stop codon mutation. However, there was no significant difference in the frequency of amino acid changes among HBeAg-HBV carriers. The mean number of core amino acid changes of liver cirrhosis patients, chronic active hepatitis patients, chronic persistent hepatitis patients, and asymptomatic carriers were 2.7±1.5, 6.0±2.2, 4.7±1.2, and 8.4±5.3, respectively. We detected hot spots for core mutations, which showed characteristic localizations and specific substitutions: Gly-87, Leu-97, and Thr-130 were detected exclusively in patients with chronic liver disease with or without HBeAg. To address further the relationship between frequency of core mutations and the presence of the precore stop codon mutation, we investigated the precore/core nucleotide sequence serially along with seroconversion in three patients with chronic hepatitis B in whom the hepatitis either became inactive or remained active after the seroconversion. Emergence of the precore stop codon mutation and a significant increase in core amino acid changes after seroconversion were noted in all three patients. Our results suggest a close association between the frequency of core amino acid changes and the presence of the precore stop codon mutation; some characteristic core mutations may be associated with the clinical course of chronic hepatitis B in Japanese patients.
引用
收藏
页码:611 / 622
页数:11
相关论文
共 34 条
  • [21] Identification the relationship between hepatitis B virus YIDD/YVDD and HBV PC-BCP mutation
    Yan, Li
    Hou, Linjin
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 916 - 917
  • [22] Sanger sequencing versus INNO-LiPA® HBV PreCore assay for routine detection of precore and basal core promoter mutations in hepatitis virus B chronically infected patients
    Alidjinou, E. K.
    Bocket, L.
    Pigot, V.
    Lambert, V.
    Hallaert, C.
    Canva, V.
    Hober, D.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2018, 90 (04) : 277 - 279
  • [23] HBsAg, HBeAg and HBV DNA level changes and precore/basal core promoter mutations in the natural history of chronic hepatitis B in Indonesian patients
    Meta Dewi Turyadi
    Susan Irawati Thedja
    Alida Roswita Ie
    Korri Elvanita Harahap
    Martono El-Khobar
    David Handojo Roni
    Hepatology International, 2013, 7 : 969 - 980
  • [24] HBsAg, HBeAg and HBV DNA level changes and precore/basal core promoter mutations in the natural history of chronic hepatitis B in Indonesian patients
    Turyadi
    Thedja, Meta Dewi
    Ie, Susan Irawati
    Harahap, Alida Roswita
    El-Khobar, Korri Elvanita
    Roni, Martono
    Muljono, David Handojo
    HEPATOLOGY INTERNATIONAL, 2013, 7 (04) : 969 - 980
  • [25] CHANGES IN THE HEPATITIS-B VIRUS PRECORE AND CORE REGIONS IN ASSOCIATION WITH THE DISAPPEARANCE OF HEPATITIS-B E-ANTIGEN IN PATIENTS WITH CHRONIC HEPATITIS-B
    NAKAYAMA, J
    NAKANISHI, T
    ARATAKI, K
    OBATAKE, T
    MORIYA, T
    KAJIYAMA, G
    INTERNAL MEDICINE, 1995, 34 (05) : 319 - 325
  • [26] Hepatitis B virus genotypes, precore mutations, and basal core promoter mutations in HBV-infected Chinese patients with persistently normal alanine aminotransferase and low serum HBV-DNA levels
    Shi, Ming
    Zhang, Yong
    Zhang, Jing
    Liu, Wei
    Xing, Lu
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2012, 16 (01) : 52 - 56
  • [27] Distinct quasispecies characteristics and positive selection within precore/core gene in hepatitis B virus HBV associated acute-on-chronic liver failure
    Chen, Li
    Zheng, Cai-Xia
    Lin, Ming-hua
    Huang, Zu-Xiong
    Chen, Rong-hua
    Li, Qin-guang
    Li, Qing
    Chen, Pan
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 (06) : 1040 - 1046
  • [28] Different mutation rates in the basal core promoter and precore regions between hepatitis B virus subgenotype F1b clusters
    Martinez, Micaela
    Elizalde, Maria Mercedes
    Giadans, Cecilia Graciela
    Monzani, Cecilia
    Campos, Rodolfo
    Flichman, Diego
    JOURNAL OF VIRAL HEPATITIS, 2023, 30 (06) : 540 - 543
  • [29] The Relationship between Intrahepatic Distribution of Hepatitis B Virus Core Antigen and Serum ALT, HBV DNA Levels and HBeAg Status
    Qing He
    Qi-yuan Tang
    Xiao-hua Le
    De-liang Lv
    Xiang-mei Zhang
    Fei-jian Ao
    Yi-min Tang
    Shan Huang
    John Nunnari
    Gui-lin Yang
    InfectionInternational(ElectronicEdition), 2012, 1 (02) : 84 - 90
  • [30] The rtL229 substitutions in the reverse transcriptase region of hepatitis B virus (HBV) polymerase are potentially associated with lamivudine resistance as a compensatory mutation
    Ji, Dong
    Liu, Yan
    Li, Le
    Xu, Zhihui
    Si, Lan-Lan
    Dai, Jiu-Zeng
    Li, Xiaodong
    Wang, Lin
    Yao, Zengtao
    Xin, Shao-Jie
    Chen, Guo-Feng
    Xu, Dongping
    JOURNAL OF CLINICAL VIROLOGY, 2012, 54 (01) : 66 - 72